A newly published report, “Fairness in Precision Medicine,” by Kadija Ferryman, PhD, and Mikaela Pitcan, seeks to better understand how bias could impact biomedical research into precision medicine.
Bias in medicine research exists in datasets and in outcomes, according to a newly published report, “Fairness in Precision Medicine.”
The report, by Kadija Ferryman, PhD, and Mikaela Pitcan, supported by the Robert Wood Johnson Foundation, seeks to better understand how bias could impact biomedical research into precision medicine.
In 2017, Ferryman and Pitcan conducted 21 qualitative interviews, via phone or in person, with biomedical researchers, bioethicists, technologists, and patient advocates. In the semi-structured interviews, the researchers asked respondents to discuss the potential areas where bias could present itself. The respondents told Ferryman and Pitcan that datasets themselves can become unintentionally biased in a variety of contexts:
Moreover, say the authors, bias may influence the outcomes of precision medicine for patients and the healthcare system:
According to Ferryman and Pitcan, although precision medicine has the potential to transform healthcare for the better, there remains work ahead to ensure that structural determinants of health are acknowledged and addressed and to institute policies that will keep data from being used to marginalize vulnerable people.
“Above all,” say the authors, “patients and the public need to be engaged in this endeavor both to guarantee its success and to hold other actors accountable for potential misuses or misunderstandings about when and how their data should be used.”
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More